**8. Conclusion**

Atrial Fibrillation is a commonly prevalent arrhythmia with increasing prevalence and incidence. There have been significant development in the field of AF treatment in recent years which has changed physician's outlook towards this growing arrhythmia epidemic. With several recent RCTs and other wealth of scientific evidence, benefits of early rhythm control is being increasingly recognized. Catheter ablation is safe and effective, feasible in controlling AF burden, improving quality of life, reduce hospitalization, improve heart failure symptoms and exercise capacity, reduce hospitalization and offers mortality benefit in patients with reduced LV systolic function. Mapping and ablation technology has significantly improved in recent years and is still growing and evolving. Various modalities for ablation such as RF along with its different strategic ramifications such as VoM alcohol ablation, substrate modification, Cryo-Ablation, PFA or Hybrid Convergent procedures have opened up more treatment choices available to both Paroxysmal and Persistent/Long standing persistent Atrial Fibrillation patients. Stroke prevention with LAA occlusion has proven effective and successful in patients who cannot tolerate or have a contraindication for long term anticoagulation.
